News collection http://lrd.kuleuven.be daily 1 2012-02-01T03:16:29Z Doctoral researchers put tech transfer theory into practice http://lrd.kuleuven.be/en/news/doctoral-researchers-put-tech-transfer-theory-into-practice No publisher Kristof Haex 2013-04-24T07:03:10Z News Item Cargill buys dietary fibre technology from Fugeia http://lrd.kuleuven.be/en/news/cargill-buys-dietary-fibre-technology-from-fugeia No publisher Kristof Haex 2013-03-07T15:25:56Z News Item One treatment for HIV and an aggressive form of leukemia? http://lrd.kuleuven.be/en/news/one-treatment-for-hiv-and-leukemia No publisher Kristof Haex 2013-02-07T13:10:04Z News Item Alliance of translational research centres established to accelerate global drug development http://lrd.kuleuven.be/en/news/alliance-of-translational-research-centres-established No publisher Kristof Haex 2013-01-21T15:48:49Z News Item Oncodesign and the KU Leuven Laboratory for Neurobiology and Gene Therapy enter into a research collaboration for advancing drug discovery efforts with Ipsen in Parkinson's disease http://lrd.kuleuven.be/en/news/Oncodesign-the-kuleuven-laboratory-for-neurobiology-and-gene-therapy-enter-into-a-research-collaboration No publisher Kristof Haex 2012-12-19T09:47:27Z News Item U.S. FDA approves ThromboGenics’ JETREA® (Ocriplasmin) for the treatment of symptomatic Vitreomacular Adhesion (VMA) http://lrd.kuleuven.be/en/news/us-fda-approves-thrombogenics-ocriplasmin No publisher Kristof Haex 2013-01-23T11:25:20Z News Item Siemens acquires LMS International http://lrd.kuleuven.be/en/news/siemens-acquires-lms-international No publisher Kristof Haex 2012-11-08T13:29:59Z News Item KU Leuven spin-off ThromboGenics enters into commercialization agreement for ocriplasmin http://lrd.kuleuven.be/en/news/ku-leuven-spin-off-thrombogenics-enters-into-commercialisation-agreement No publisher Kristof Haex 2012-03-19T14:09:41Z News Item LayerWise builds the world’s first patient-specific lower jaw using laser technology http://lrd.kuleuven.be/en/news/layerwise-builds-lower-jaw No publisher Kristof Haex 2012-02-06T09:16:14Z News Item ADx NeuroSciences NV enters into exclusive license agreement with KU Leuven for the development of antibodies used in dementia diagnosis http://lrd.kuleuven.be/en/news/adx-neurosciences-enters-into-exclusive-license-agreement-with-kuleuven No publisher Kristof Haex 2012-03-16T10:04:48Z News Item LRD has moved to Waaistraat 6 http://lrd.kuleuven.be/en/news/lrd-has-moved-to-waaistraat-6 No publisher Kristof Haex 2012-02-03T14:16:57Z News Item Karyopharm Therapeutics Inc. and KU Leuven Sign Exclusive Collaboration for the Discovery of Novel CRM1/Exportin 1 Inhibitors http://lrd.kuleuven.be/en/news/karyopharm-and-kuleuven-sign-collaboration-agreement No publisher Kristof Haex 2012-03-16T10:04:53Z News Item Aeschylus provides final push for applied research http://lrd.kuleuven.be/en/news/aeschylus-provides-final-push-for-applied-research No publisher Kristof Haex 2012-03-16T10:04:46Z News Item KU Leuven floor sensor wins Aerospace Award at Stanford University workshop http://lrd.kuleuven.be/en/news/k.u.leuven-floor-sensor-wins-aerospace-award No publisher Kristof Haex 2012-03-16T10:04:50Z News Item Cambridge, Heidelberg and Leuven sign constitution Health Axis Europe http://lrd.kuleuven.be/en/news/cambridge-heidelberg-and-leuven-sign-constitution-health-axis-europe No publisher Kristof Haex 2012-03-16T10:04:47Z News Item